Red Blood Cell Transfusion Not Independent Risk Factor for Thrombosis
New research has not found RBC transfusion to be an independent risk factor for venous or arterial thrombosis in hospitalized patients.
Deep Vein Thrombosis
ASH 2020 Guidelines on Venous Thromboembolism Management
The American Society of Hematology released evidence-based guidelines for the treatment of DVT and PE in patients without cancer.
Deep Vein Thrombosis Detection in Patients With Hemophilia A Undergoing Total Knee Arthroplasty
A prospective, single-center study aimed to determine the prevalence of DVT after TKA among patients with hemophilia A and found that contrast-enhanced CT led to better detection compared with ultrasound.
BSH Guideline Update for Assays Used in Hemostasis and Thrombosis
The British Society of Haematology released updates to 2 previous guidelines to help clinical laboratories with assays for coagulant diagnostic services.
Safety, Efficacy of Apixaban or Rivaroxaban in Upper Extremity Deep Vein Thrombosis
Apixaban or rivaroxaban may be as safe and effective at treating upper extremity deep vein thrombosis as low molecular weight heparin and warfarin.
Deep Vein Thrombosis Incidence and Pulmonary Embolism Risk Stratification
High or intermediate PE risk status was linked with lower rates of DVT, but asymptomatic DVT was more often found with high or intermediate PE risk.
Metabolic Syndrome May Up Risk for VTE Recurrence After DVT
Significantly higher odds seen for all four components of MetS, with largest risk increase for hyperlipidemia
Rivaroxaban May Be the Best Strategy for Deep Vein Thrombosis Prevention in Total Knee Replacement
A review and meta-analysis of 25 randomized controlled trials showed that single-agent treatment strategies were generally more effective than combination strategies.
Extended Oral Anticoagulation Therapy for First Unprovoked Deep Vein Thrombosis
Continuing warfarin therapy for 18 months after an initial 6-month course decreased incidence of venous thrombosis and major bleeding.
Risk Factors for Recurrent Venous Thromboembolism in Patients With Sickle Cell Disease
Patients with severe sickle cell disease were more than twice as likely to experience recurrent thromboembolism compared with patients with less severe disease.
- Loading...
Loading...
Next post in Thrombotic Disorders
Loading... 
Loading...